News | January 28, 2026
Parse Biosciences unveils integrated immune profiling in Trailmaker Platform
The new functionality complements Parse’s existing Evercode immune products
The new functionality complements Parse’s existing Evercode immune products
DME is among the most challenging retinal diseases to treat and has long served as a proving ground for therapies that ultimately become first-line standard of care in retinal diseases
Ventyx's clinical pipeline includes multiple small molecules with potential for oral therapies addressing chronic inflammation
The company announced that it has been granted patent covering “Substituted Ethylamine Fused Heterocyclic Mescaline Derivatives.”
The study will run across 18 sites and enroll roughly 200 patients over 24 months
The funding will accelerate Sinopia’s data-driven drug discovery efforts
CX-5461 is “the world's first and most advanced G-quadruplex (G4) stabilizer in development
Nona aims to help global biopharmaceutical companies fast-track clinical trial initiation without compromising scientific rigor or quality standards
The new single-use commercial facility will be among India’s largest, featuring advanced technologies to produce high-quality biologics and specialty pharmaceuticals
Desai is currently serving the company as Group Finance Controller
Subscribe To Our Newsletter & Stay Updated
